Green Thumb Industries Inc.
Green Thumb Industries Inc. GTBIF Peers
See (GTBIF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GTBIF | $5.51 | +4.95% | 1.3B | 26.14 | $0.21 | N/A |
| MKGAF | $131.25 | +1.16% | 57.5B | 17.75 | $7.45 | +1.90% |
| MKKGY | $25.94 | -1.48% | 55.8B | 17.40 | $1.49 | +1.93% |
| TKPHF | $32.13 | +13.33% | 50.6B | 69.85 | $0.46 | +4.14% |
| HLNCF | $5.15 | -0.68% | 46.3B | 24.52 | $0.21 | +1.19% |
| IPSEY | $30.15 | +3.79% | 39.9B | 24.12 | $1.25 | +0.86% |
| SDZNY | $54.67 | +1.06% | 23.5B | -2731.50 | -$0.02 | +1.24% |
| TEVJF | $15.58 | -12.47% | 17.9B | -13.55 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| SGIOF | $18.05 | +0.00% | 15.3B | 13.04 | $1.38 | +2.31% |
Stock Comparison
GTBIF vs MKGAF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, MKGAF has a market cap of 57.5B. Regarding current trading prices, GTBIF is priced at $5.51, while MKGAF trades at $131.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas MKGAF's P/E ratio is 17.75. In terms of profitability, GTBIF's ROE is +0.03%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs MKKGY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, MKKGY has a market cap of 55.8B. Regarding current trading prices, GTBIF is priced at $5.51, while MKKGY trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas MKKGY's P/E ratio is 17.40. In terms of profitability, GTBIF's ROE is +0.03%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs TKPHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, TKPHF has a market cap of 50.6B. Regarding current trading prices, GTBIF is priced at $5.51, while TKPHF trades at $32.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas TKPHF's P/E ratio is 69.85. In terms of profitability, GTBIF's ROE is +0.03%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, GTBIF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HLNCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HLNCF has a market cap of 46.3B. Regarding current trading prices, GTBIF is priced at $5.51, while HLNCF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HLNCF's P/E ratio is 24.52. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs IPSEY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, IPSEY has a market cap of 39.9B. Regarding current trading prices, GTBIF is priced at $5.51, while IPSEY trades at $30.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas IPSEY's P/E ratio is 24.12. In terms of profitability, GTBIF's ROE is +0.03%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, GTBIF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SDZNY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SDZNY has a market cap of 23.5B. Regarding current trading prices, GTBIF is priced at $5.51, while SDZNY trades at $54.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SDZNY's P/E ratio is -2731.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, GTBIF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs TEVJF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, TEVJF has a market cap of 17.9B. Regarding current trading prices, GTBIF is priced at $5.51, while TEVJF trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas TEVJF's P/E ratio is -13.55. In terms of profitability, GTBIF's ROE is +0.03%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, GTBIF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs ESALY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, GTBIF is priced at $5.51, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas ESALY's P/E ratio is 20.54. In terms of profitability, GTBIF's ROE is +0.03%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, GTBIF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SGIOF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SGIOF has a market cap of 15.3B. Regarding current trading prices, GTBIF is priced at $5.51, while SGIOF trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SGIOF's P/E ratio is 13.04. In terms of profitability, GTBIF's ROE is +0.03%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, GTBIF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SGIOY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SGIOY has a market cap of 15.2B. Regarding current trading prices, GTBIF is priced at $5.51, while SGIOY trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SGIOY's P/E ratio is 12.91. In terms of profitability, GTBIF's ROE is +0.03%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, GTBIF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs BIOVF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, GTBIF is priced at $5.51, while BIOVF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas BIOVF's P/E ratio is 24.38. In terms of profitability, GTBIF's ROE is +0.03%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs IPSEF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, GTBIF is priced at $5.51, while IPSEF trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas IPSEF's P/E ratio is 23.57. In terms of profitability, GTBIF's ROE is +0.03%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, GTBIF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SFOSF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SFOSF has a market cap of 8.4B. Regarding current trading prices, GTBIF is priced at $5.51, while SFOSF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SFOSF's P/E ratio is 13.40. In terms of profitability, GTBIF's ROE is +0.03%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, GTBIF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs ESAIY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, ESAIY has a market cap of 8.1B. Regarding current trading prices, GTBIF is priced at $5.51, while ESAIY trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas ESAIY's P/E ratio is 25.46. In terms of profitability, GTBIF's ROE is +0.03%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, GTBIF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs ESALF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, ESALF has a market cap of 7.8B. Regarding current trading prices, GTBIF is priced at $5.51, while ESALF trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas ESALF's P/E ratio is 24.55. In terms of profitability, GTBIF's ROE is +0.03%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, GTBIF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HKMPY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HKMPY has a market cap of 6.1B. Regarding current trading prices, GTBIF is priced at $5.51, while HKMPY trades at $55.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HKMPY's P/E ratio is 17.23. In terms of profitability, GTBIF's ROE is +0.03%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, GTBIF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HKMPF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HKMPF has a market cap of 5.9B. Regarding current trading prices, GTBIF is priced at $5.51, while HKMPF trades at $26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HKMPF's P/E ratio is 16.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, GTBIF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs GZPHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, GZPHF has a market cap of 5.7B. Regarding current trading prices, GTBIF is priced at $5.51, while GZPHF trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas GZPHF's P/E ratio is 9.70. In terms of profitability, GTBIF's ROE is +0.03%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, GTBIF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HLUBF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HLUBF has a market cap of 5.2B. Regarding current trading prices, GTBIF is priced at $5.51, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HLUBF's P/E ratio is 10.44. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, GTBIF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SGFEF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, GTBIF is priced at $5.51, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SGFEF's P/E ratio is 25.35. In terms of profitability, GTBIF's ROE is +0.03%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, GTBIF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs WIBFF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, GTBIF is priced at $5.51, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, GTBIF's ROE is +0.03%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, GTBIF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HLBBF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, GTBIF is priced at $5.51, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HLBBF's P/E ratio is 11.73. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, GTBIF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs LVZPF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, LVZPF has a market cap of 4.2B. Regarding current trading prices, GTBIF is priced at $5.51, while LVZPF trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, GTBIF's ROE is +0.03%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, GTBIF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs APNHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, APNHF has a market cap of 4.1B. Regarding current trading prices, GTBIF is priced at $5.51, while APNHF trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas APNHF's P/E ratio is 16.43. In terms of profitability, GTBIF's ROE is +0.03%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, GTBIF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs ULIHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, GTBIF is priced at $5.51, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, GTBIF's ROE is +0.03%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, GTBIF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HYPMY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, GTBIF is priced at $5.51, while HYPMY trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HYPMY's P/E ratio is 21.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, GTBIF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs APNHY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, GTBIF is priced at $5.51, while APNHY trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas APNHY's P/E ratio is 12.13. In terms of profitability, GTBIF's ROE is +0.03%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs INVVY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, GTBIF is priced at $5.51, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas INVVY's P/E ratio is -62.42. In terms of profitability, GTBIF's ROE is +0.03%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, GTBIF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs IZQVF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, GTBIF is priced at $5.51, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, GTBIF's ROE is +0.03%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, GTBIF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs LBTSF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, GTBIF is priced at $5.51, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas LBTSF's P/E ratio is 222.67. In terms of profitability, GTBIF's ROE is +0.03%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, GTBIF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs DNPUF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, DNPUF has a market cap of 2.6B. Regarding current trading prices, GTBIF is priced at $5.51, while DNPUF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas DNPUF's P/E ratio is 15.98. In terms of profitability, GTBIF's ROE is +0.03%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, GTBIF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HMDCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, GTBIF is priced at $5.51, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, GTBIF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HTSUF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, GTBIF is priced at $5.51, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HTSUF's P/E ratio is 16.18. In terms of profitability, GTBIF's ROE is +0.03%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, GTBIF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs THCBF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, GTBIF is priced at $5.51, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas THCBF's P/E ratio is -0.10. In terms of profitability, GTBIF's ROE is +0.03%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, GTBIF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SHEZF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SHEZF has a market cap of 2.3B. Regarding current trading prices, GTBIF is priced at $5.51, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, GTBIF's ROE is +0.03%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CHSYF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, GTBIF is priced at $5.51, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, GTBIF's ROE is +0.03%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs DMPHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, GTBIF is priced at $5.51, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, GTBIF's ROE is +0.03%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, GTBIF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs LJUIF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, GTBIF is priced at $5.51, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, GTBIF's ROE is +0.03%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, GTBIF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs ARSUF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, GTBIF is priced at $5.51, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, GTBIF's ROE is +0.03%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, GTBIF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs TSMRF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, GTBIF is priced at $5.51, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas TSMRF's P/E ratio is 10.99. In terms of profitability, GTBIF's ROE is +0.03%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, GTBIF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs NPNKF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, NPNKF has a market cap of 1.8B. Regarding current trading prices, GTBIF is priced at $5.51, while NPNKF trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas NPNKF's P/E ratio is 7.81. In terms of profitability, GTBIF's ROE is +0.03%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, GTBIF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs YIHCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, YIHCF has a market cap of 1.7B. Regarding current trading prices, GTBIF is priced at $5.51, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, GTBIF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs EVOTF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, GTBIF is priced at $5.51, while EVOTF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas EVOTF's P/E ratio is -8.38. In terms of profitability, GTBIF's ROE is +0.03%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, GTBIF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SMDPY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, GTBIF is priced at $5.51, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SMDPY's P/E ratio is 10.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, GTBIF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs MITPF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, GTBIF is priced at $5.51, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas MITPF's P/E ratio is -10.81. In terms of profitability, GTBIF's ROE is +0.03%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, GTBIF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CHIZF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CHIZF has a market cap of 1.6B. Regarding current trading prices, GTBIF is priced at $5.51, while CHIZF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CHIZF's P/E ratio is 15.63. In terms of profitability, GTBIF's ROE is +0.03%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, GTBIF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs KARBF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, GTBIF is priced at $5.51, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas KARBF's P/E ratio is 262.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to KARBF's ROE of N/A. Regarding short-term risk, GTBIF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs NPPNY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, NPPNY has a market cap of 1.5B. Regarding current trading prices, GTBIF is priced at $5.51, while NPPNY trades at $5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas NPPNY's P/E ratio is 6.60. In terms of profitability, GTBIF's ROE is +0.03%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs TWAPF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, GTBIF is priced at $5.51, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas TWAPF's P/E ratio is 9.59. In terms of profitability, GTBIF's ROE is +0.03%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs GNMLF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, GTBIF is priced at $5.51, while GNMLF trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas GNMLF's P/E ratio is 9.67. In terms of profitability, GTBIF's ROE is +0.03%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, GTBIF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CASBF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CASBF has a market cap of 1.2B. Regarding current trading prices, GTBIF is priced at $5.51, while CASBF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CASBF's P/E ratio is -17.81. In terms of profitability, GTBIF's ROE is +0.03%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, GTBIF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SWGHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, GTBIF is priced at $5.51, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, GTBIF's ROE is +0.03%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, GTBIF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SHPHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, GTBIF is priced at $5.51, while SHPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, GTBIF's ROE is +0.03%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, GTBIF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs KSPHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, KSPHF has a market cap of 1B. Regarding current trading prices, GTBIF is priced at $5.51, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas KSPHF's P/E ratio is 12.75. In terms of profitability, GTBIF's ROE is +0.03%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs KKPCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, KKPCF has a market cap of 980.3M. Regarding current trading prices, GTBIF is priced at $5.51, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas KKPCF's P/E ratio is 10.63. In terms of profitability, GTBIF's ROE is +0.03%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, GTBIF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs BIOGY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, GTBIF is priced at $5.51, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas BIOGY's P/E ratio is 30.47. In terms of profitability, GTBIF's ROE is +0.03%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, GTBIF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs LVTTF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, LVTTF has a market cap of 894.1M. Regarding current trading prices, GTBIF is priced at $5.51, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, GTBIF's ROE is +0.03%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, GTBIF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs EVRRF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, EVRRF has a market cap of 893.1M. Regarding current trading prices, GTBIF is priced at $5.51, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, GTBIF's ROE is +0.03%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, GTBIF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs NRXCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, NRXCF has a market cap of 846.4M. Regarding current trading prices, GTBIF is priced at $5.51, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, GTBIF's ROE is +0.03%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, GTBIF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CSWYF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, GTBIF is priced at $5.51, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, GTBIF's ROE is +0.03%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, GTBIF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs ELTP Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, ELTP has a market cap of 794.8M. Regarding current trading prices, GTBIF is priced at $5.51, while ELTP trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas ELTP's P/E ratio is -37.20. In terms of profitability, GTBIF's ROE is +0.03%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, GTBIF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs AGYTF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, GTBIF is priced at $5.51, while AGYTF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, GTBIF's ROE is +0.03%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, GTBIF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs TCNNF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, TCNNF has a market cap of 725.1M. Regarding current trading prices, GTBIF is priced at $5.51, while TCNNF trades at $3.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas TCNNF's P/E ratio is -4.80. In terms of profitability, GTBIF's ROE is +0.03%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, GTBIF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs NIKA Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, GTBIF is priced at $5.51, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas NIKA's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, GTBIF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs TRXPF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, GTBIF is priced at $5.51, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, GTBIF's ROE is +0.03%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, GTBIF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CURLF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CURLF has a market cap of 633.2M. Regarding current trading prices, GTBIF is priced at $5.51, while CURLF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CURLF's P/E ratio is -2.53. In terms of profitability, GTBIF's ROE is +0.03%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, GTBIF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs TRSSF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, GTBIF is priced at $5.51, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, GTBIF's ROE is +0.03%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, GTBIF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs SWDCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, SWDCF has a market cap of 580.2M. Regarding current trading prices, GTBIF is priced at $5.51, while SWDCF trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas SWDCF's P/E ratio is 60.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, GTBIF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs PKBFF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, PKBFF has a market cap of 549.2M. Regarding current trading prices, GTBIF is priced at $5.51, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas PKBFF's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, GTBIF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CCHWF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, GTBIF is priced at $5.51, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, GTBIF's ROE is +0.03%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, GTBIF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs AIHLF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, GTBIF is priced at $5.51, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, GTBIF's ROE is +0.03%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, GTBIF is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs BOIRF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, GTBIF is priced at $5.51, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, GTBIF's ROE is +0.03%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, GTBIF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs PEXXF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, GTBIF is priced at $5.51, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to PEXXF's ROE of N/A. Regarding short-term risk, GTBIF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs KHTRF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, KHTRF has a market cap of 420.4M. Regarding current trading prices, GTBIF is priced at $5.51, while KHTRF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas KHTRF's P/E ratio is 60.29. In terms of profitability, GTBIF's ROE is +0.03%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, GTBIF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs GLASF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, GLASF has a market cap of 416.5M. Regarding current trading prices, GTBIF is priced at $5.51, while GLASF trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas GLASF's P/E ratio is -65.56. In terms of profitability, GTBIF's ROE is +0.03%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, GTBIF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HUMDF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, GTBIF is priced at $5.51, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, GTBIF's ROE is +0.03%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, GTBIF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs EOFBF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, EOFBF has a market cap of 330.3M. Regarding current trading prices, GTBIF is priced at $5.51, while EOFBF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas EOFBF's P/E ratio is -2.33. In terms of profitability, GTBIF's ROE is +0.03%, compared to EOFBF's ROE of -1.26%. Regarding short-term risk, GTBIF is more volatile compared to EOFBF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs BHCCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, BHCCF has a market cap of 293.9M. Regarding current trading prices, GTBIF is priced at $5.51, while BHCCF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, GTBIF's ROE is +0.03%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, GTBIF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CPHRF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CPHRF has a market cap of 235.7M. Regarding current trading prices, GTBIF is priced at $5.51, while CPHRF trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CPHRF's P/E ratio is 25.56. In terms of profitability, GTBIF's ROE is +0.03%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, GTBIF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs PLNHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, GTBIF is priced at $5.51, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, GTBIF's ROE is +0.03%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, GTBIF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs VRNOF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, VRNOF has a market cap of 178.1M. Regarding current trading prices, GTBIF is priced at $5.51, while VRNOF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas VRNOF's P/E ratio is -0.49. In terms of profitability, GTBIF's ROE is +0.03%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, GTBIF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CRLBF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CRLBF has a market cap of 167.2M. Regarding current trading prices, GTBIF is priced at $5.51, while CRLBF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CRLBF's P/E ratio is -2.06. In terms of profitability, GTBIF's ROE is +0.03%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, GTBIF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs PHCUF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, PHCUF has a market cap of 137.2M. Regarding current trading prices, GTBIF is priced at $5.51, while PHCUF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas PHCUF's P/E ratio is 515.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, GTBIF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs COPHF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, GTBIF is priced at $5.51, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas COPHF's P/E ratio is -0.02. In terms of profitability, GTBIF's ROE is +0.03%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, GTBIF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs NWPN Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, GTBIF is priced at $5.51, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas NWPN's P/E ratio is -0.04. In terms of profitability, GTBIF's ROE is +0.03%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, GTBIF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CHALF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CHALF has a market cap of 116.3M. Regarding current trading prices, GTBIF is priced at $5.51, while CHALF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CHALF's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, GTBIF is more volatile compared to CHALF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs HLTRF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, HLTRF has a market cap of 115.5M. Regarding current trading prices, GTBIF is priced at $5.51, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, GTBIF's ROE is +0.03%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, GTBIF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs LPCUF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, GTBIF is priced at $5.51, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, GTBIF's ROE is +0.03%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, GTBIF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CNVCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, GTBIF is priced at $5.51, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, GTBIF's ROE is +0.03%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, GTBIF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs CBWTF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, CBWTF has a market cap of 100.8M. Regarding current trading prices, GTBIF is priced at $5.51, while CBWTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas CBWTF's P/E ratio is 3.82. In terms of profitability, GTBIF's ROE is +0.03%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, GTBIF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs BIOYF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, BIOYF has a market cap of 99.5M. Regarding current trading prices, GTBIF is priced at $5.51, while BIOYF trades at $8.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas BIOYF's P/E ratio is 17.69. In terms of profitability, GTBIF's ROE is +0.03%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, GTBIF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs GRUSF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, GRUSF has a market cap of 96.2M. Regarding current trading prices, GTBIF is priced at $5.51, while GRUSF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas GRUSF's P/E ratio is -7.76. In terms of profitability, GTBIF's ROE is +0.03%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, GTBIF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs LOVFF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, LOVFF has a market cap of 95.1M. Regarding current trading prices, GTBIF is priced at $5.51, while LOVFF trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas LOVFF's P/E ratio is 10.40. In terms of profitability, GTBIF's ROE is +0.03%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, GTBIF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs LRDSF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, LRDSF has a market cap of 84.2M. Regarding current trading prices, GTBIF is priced at $5.51, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, GTBIF's ROE is +0.03%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, GTBIF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs GBLP Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, GBLP has a market cap of 83M. Regarding current trading prices, GTBIF is priced at $5.51, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas GBLP's P/E ratio is -0.67. In terms of profitability, GTBIF's ROE is +0.03%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, GTBIF is more volatile compared to GBLP. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs DUTV Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, DUTV has a market cap of 76M. Regarding current trading prices, GTBIF is priced at $5.51, while DUTV trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas DUTV's P/E ratio is N/A. In terms of profitability, GTBIF's ROE is +0.03%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, GTBIF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs MEDXF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, MEDXF has a market cap of 75.4M. Regarding current trading prices, GTBIF is priced at $5.51, while MEDXF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas MEDXF's P/E ratio is 29.23. In terms of profitability, GTBIF's ROE is +0.03%, compared to MEDXF's ROE of +0.11%. Regarding short-term risk, GTBIF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs ABSCF Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, ABSCF has a market cap of 74.8M. Regarding current trading prices, GTBIF is priced at $5.51, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, GTBIF's ROE is +0.03%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, GTBIF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for GTBIF.
GTBIF vs EOFBY Comparison
GTBIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTBIF stands at 1.3B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, GTBIF is priced at $5.51, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTBIF currently has a P/E ratio of 26.14, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, GTBIF's ROE is +0.03%, compared to EOFBY's ROE of N/A. Regarding short-term risk, GTBIF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for GTBIF.